脑部放疗，上午比下午敏感许多！
2 e9 {' I1 [, }8 ?& X, w
e3 b% C, |% x) j. ~2 [: r& K, T9 G2 N! J
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.8 o7 w- T7 e) x+ _. [
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?' i, e# y8 S- `- K
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
/ Y( L! F3 M* P5 p$ u- LSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
$ v& P3 P& T9 v3 q1 m9 v: g) k |8 `+ o3 | j
Abstract
4 W- o* b1 M! l, r+ MBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
- n6 l1 a* O. H, q N
. a8 {7 U" Q( S( Y+ ]/ {METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.9 S# q2 l, p3 s# S8 d' p
' P6 _ Y- s) q) z8 z1 ~$ w8 H3 L0 u
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).+ O' A9 V8 V+ P5 H; l
5 S& j- h1 i$ P6 k2 y: v, I r) k
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
9 P/ B- {0 g4 K' J {9 G1 G5 [ ]4 q, t; \# ?, ?1 P6 c
|
显身卡
